 Connection
Martin McCarter to Neoplasms
This is a "connection" page, showing publications Martin McCarter has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.032 |
|
|
|
-
Tobin RP, Davis D, Jordan KR, McCarter MD. The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients. J Leukoc Biol. 2017 08; 102(2):381-391.
Score: 0.184
-
Jordan KR, Kapoor P, Spongberg E, Tobin RP, Gao D, Borges VF, McCarter MD. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients. Cancer Immunol Immunother. 2017 Apr; 66(4):503-513.
Score: 0.184
-
Baumgartner JM, McCarter MD. Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery. Surgery. 2009 Apr; 145(4):345-50.
Score: 0.107
-
Clarke JH, Cha JY, Walsh MD, Harken AH, McCarter MD. Dendritic cells as therapeutic adjuncts in surgical disease. Surgery. 2005 Nov; 138(5):844-50.
Score: 0.084
-
Eljilany I, Coleman S, Tan AC, McCarter MD, Carpten J, Colman H, Naqash AR, Puzanov I, Arnold SM, Churchman ML, Spakowicz D, Salhia B, Marin J, Ganesan S, Ratan A, Shriver C, Hwu P, Dalton WS, Weiner GJ, Conejo-Garcia JR, Rodriguez P, Tarhini AA. Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy. Cells. 2024 12 03; 13(23).
Score: 0.079
-
Katsnelson EN, Spengler A, Domenico J, Couts KL, Loh L, Gapin L, McCarter MD, Tobin RP. Dysfunctional states of unconventional T-cell subsets in cancer. J Leukoc Biol. 2024 01 05; 115(1):36-46.
Score: 0.074
-
Hoskins EL, Samorodnitsky E, Wing MR, Reeser JW, Hopkins JF, Murugesan K, Kuang Z, Vella R, Stein L, Risch Z, Yu L, Adebola S, Paruchuri A, Carpten J, Chahoud J, Edge S, Kolesar J, McCarter M, Nepple KG, Reilley M, Scaife C, Tripathi A, Single N, Huang RSP, Albacker LA, Roychowdhury S. Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. JCO Precis Oncol. 2023 01; 7:e2200300.
Score: 0.069
-
McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol. 2001 Jan-Feb; 8(1):38-43.
Score: 0.060
-
Davis B, McDermott S, McCarter M, Ortaglia A. Population-based mortality data suggests remediation is modestly effective in two Montana Superfund counties. Environ Geochem Health. 2019 Apr; 41(2):803-816.
Score: 0.051
-
McCarter MD, Gentilini OD, Gomez ME, Daly JM. Preoperative oral supplement with immunonutrients in cancer patients. JPEN J Parenter Enteral Nutr. 1998 Jul-Aug; 22(4):206-11.
Score: 0.051
-
Bruno TC, French JD, Jordan KR, Ramirez O, Sippel TR, Borges VF, Haugen BR, McCarter MD, Waziri A, Slansky JE. Influence of human immune cells on cancer: studies at the University of Colorado. Immunol Res. 2013 Mar; 55(1-3):22-33.
Score: 0.035
-
Merkow RP, Bilimoria KY, McCarter MD, Cohen ME, Barnett CC, Raval MV, Caprini JA, Gordon HS, Ko CY, Bentrem DJ. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg. 2011 Jul; 254(1):131-7.
Score: 0.031
-
Liu X, Tang YH, Blachly J, Edge S, Jakubek YA, McCarter M, Naqash AR, Nepple KG, Osman A, Reilley MJ, Riedlinger G, Salhia B, Schneider BP, Shriver C, Churchman ML, Rounbehler RJ, Teer JK, Gillis N, Teng M. qcCHIP: an R package to identify clonal hematopoiesis variants using cohort-specific data characteristics. Bioinformatics. 2025 Sep 01; 41(9).
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|